论文部分内容阅读
目的:探究雾化吸入在耐药性肺结核治疗中的应用。方法:选取2015年3月~2016年3月本院接受治疗的60例耐药性肺结核患者,按照治疗方法的不同将其分为治疗组和对照组,各30例,对照组采用常规药物进行治疗,治疗组在常规药物的基础上采用雾化吸入进行治疗,比较两组患者的治疗效果和临床症状改善情况。结果:治疗组的临床效果和临床症状改善情况优于对照组,两组差异显著(P<0.05),有统计学意义。结论:在常规药物的基础上采用雾化吸入治疗耐药性肺结核患者具有较大的意义,可较好的提高患者的治疗效果。
Objective: To explore the application of inhalation in the treatment of drug-resistant pulmonary tuberculosis. Methods: Sixty patients with drug-resistant pulmonary tuberculosis treated in our hospital from March 2015 to March 2016 were selected and divided into treatment group and control group according to different treatment methods, 30 cases in each group. The control group was treated with conventional drugs The patients in the treatment group and the treatment group were treated with inhalation of nebulization on the basis of conventional drugs. The treatment effect and clinical symptom improvement of the two groups were compared. Results: The clinical effect and clinical symptom improvement in the treatment group was better than that in the control group, with significant difference between the two groups (P <0.05). Conclusion: It is of great significance to use atomized inhalation to treat drug-resistant pulmonary tuberculosis patients on the basis of routine drugs, which can improve the therapeutic effect of the patients.